Astana Biomed Group, an authorized Abcam distributor in Central Asia

Cell cycle

Aminopurvalanol A, cyclin-dependent kinase inhibitor (ab145052)

Description:
Potent, cell-permeable cyclin-dependent kinase inhibitor
Application:
Reactivity:
Conjugate:

Butyrolactone I, ATP-competitive cyclin-dependent kinase (CDK) inhibitor (ab141520)

Description:
Cell permeable, selective, ATP-competitive cyclin-dependent kinase (CDK) inhibitor
Application:
Reactivity:
Conjugate:

CAY10572 (PHA-767491), Cdc7 and Cdk9 kinase inhibitor (ab144419)

Description:
Potent dual Cdc7 and Cdk9 kinase inhibitor
Application:
Reactivity:
Conjugate:

CVT 313, CDK2 inhibitor (ab254327)

Description:
Potent and selective CDK2 inhibitor
Application:
Reactivity:
Conjugate:

Defactinib, FAK inhibitor (ab254452)

Description:
Potent FAK inhibitor
Application:
Reactivity:
Conjugate:

Dinaciclib, cyclin-dependent kinase (CDK) inhibitor (ab219469)

Description:
Novel, potent, selective cyclin-dependent kinase (CDK) inhibitor
Application:
Reactivity:
Conjugate:

Fisetin, sirtuin-activating compound (STAC) (ab142429)

Description:
Potent sirtuin-activating compound (STAC). Plant flavonol.
Application:
Reactivity:
Conjugate:

GSK429286A, ROCK1 and ROCK2 inhibitor (ab146581)

Description:
Selective ROCK1 and ROCK2 inhibitor
Application:
Reactivity:
Conjugate:

Human CDKN2A/p16INK4a peptide (ab105631)

Description:
Application:
Reactivity:
Conjugate:
Unconjugated

Human LATS1 (WARTS) knockout THP-1 cell line (ab277862)

Description:
Human LATS1 (WARTS) knockout THP-1 cell line
Application:
Reactivity:
Conjugate:
© 2021 Astana Biomed Group LLP. All rights reserved.